A Practical ADHD Clinician's Perspective. Jonathan Murphy, PMHNP-BC, drops the filter and speaks directly to peer clinicians about bias, deskilling, the OCPD differential, the patently false claim that stimulant response doesn't confirm ADHD, and the four types of providers patients actually encounter.

This episode covers:

• Why the podcast is now operating in the off-camera register and what that means for the audience
• The 20-year clinical trajectory from psychiatric hospital floor to specialized adult ADHD practice
• A recent LinkedIn exchange about stimulant prescribing tension and what was missing from the original post
• The OCPD differential as the diagnostic move clinicians need to make when assessing adults presenting with executive function complaints
• Why ADHD criteria require chronic functional decline across multiple domains and across the lifespan, not acute decline tied to current circumstances
• The echo chamber pattern in peer clinical discourse and what gets lost when validation replaces clinical reasoning
• The cultural stigma around stimulants and what it does to prescriber decision-making
• Why clinicians must understand their own biases before they can understand their patients
• The undiagnosed adult ADHD reality and why "it was hard for me so it should be hard for you" thinking distorts clinical judgment
• The patently false claim that stimulants work for anyone regardless of diagnosis, and why clinical discernment refutes it
• The fundamental position of stimulants and dopaminergic medication as the oldest psychiatric medication class
• Why generalists who avoid ADHD treatment become weaker clinicians by leaving a major neurodevelopmental disorder off the table
• The four types of providers patients actually encounter: the Burnt Out, the Green as Grass, the Means Well But Out to Lunch, the Means Well But Jaded
• Why the provider who actually likes their job is the fifth category worth finding
• The vetting process from The Process for adults navigating the search for a real ADHD clinician

This is the eighth episode of Actually ADHD. Previous episodes covered the optimization blueprint, the medication walkthrough, the Goldilocks Zone framework, the seven reasons medication fails, ADHD and identity, the ADHD Matrix, and the cultural critique of online ADHD discourse. The book The Process: An Adult's Guide to ADHD Medication is available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.

For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.

The ADHD Matrix. Jonathan Murphy, PMHNP-BC, names the false reality of ADHD as it exists on the internet and breaks down how smartphone technology is specifically designed to exploit the ADHD brain.

This episode covers:

• The ADHD Matrix as the false reality constructed by online ADHD discourse
• Why the ADHD brain's reliance on external stimulation makes the smartphone a unique problem
• The slot machine mechanic at the core of smartphone design: variable reward schedules, multi-modal stimulation, anticipation as dopamine driver
• Why reaching for the phone first thing in the morning makes everything else in the day harder
• The 2019 flip phone decision and what cutting out the smartphone actually produced
• Habit stacking, stupid small steps, and behavioral modification through positive reinforcement
• Friction removal as a tool for behavioral change without device dependency
• Algorithmic pricing as the next layer of dystopia: prices changing based on individual impulsivity rather than demographics
• Why data surveillance matters even when you have nothing to hide
• The "technology weaponizing ADHD brains" observation
• Creativity as the deepest stimulation source and what differentiates it from instant gratification
• Why the Reddit r/ADHD community has silenced ADDitude despite ADDitude being the credentialed industry standard
• The two ADHDs: the individual clinical diagnosis that responds to medication and behavioral skills, versus the online tribal identity that focuses on societal change
• Why the individuals who have actually improved their ADHD symptoms aren't online setting the narrative
• The return to individual change: medication, behavioral tools, and the personal assessment of whether your fails are becoming wins

This is the seventh episode of Actually ADHD. Earlier episodes covered the optimization blueprint, the medication walkthrough, the Goldilocks Zone framework, the seven reasons medication fails, the broader cultural context of ADHD and identity, and now the technological architecture exploiting the ADHD brain. The book The Process: An Adult's Guide to ADHD Medication is available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.

For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.

Navigating ADHD, the internet, and identity. Jonathan Murphy, PMHNP-BC, steps back from the medication optimization material to address the broader context patients are navigating — the cultural moment where ADHD became an online identity, the attachment system dynamics underneath identity-driven engagement with mental health content, and what actually helps versus what makes things worse.

This episode covers:

• Why the clinical experience of an adult ADHD specialist is rare and what that means for the public conversation
• The early ADHD internet creators and the TED Talk that helped turn ADHD into an identity rather than a diagnosis
• The difference between being diagnosed in childhood or adolescence and being diagnosed as a late-discovery adult
• Why a psychiatric diagnosis cannot be an identity even when the internet treats it as one
• The structural problem with online tribes forming around psychiatric diagnoses
• Why the goal of ADHD treatment is to not be defined by ADHD
• Why the internet itself is structured around money and data, not patient wellbeing
• The attachment system as a relic of childhood that shapes adult online behavior
• Parental congruence in early childhood and the long-term consequences of incongruent validation
• Why children cannot self-regulate and what validation actually accomplishes developmentally
• The connection between unhealed childhood emotional dysregulation and adult online identity dependency
• Why connecting on the internet from a lonely place creates problems rather than solutions
• The reframe back to clinical optimization: predictable repeatable behaviors and patterns
• Why advertising and marketing psychology demystify the myth of talent
• How consistency and repetition produce results that look like talent from the outside

This is the sixth episode of Actually ADHD. Earlier episodes covered the optimization blueprint, the medication walkthrough, the Goldilocks Zone framework, the seven reasons medication fails, and the prescriber-patient dynamic. The book The Process: An Adult's Guide to ADHD Medication is available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.

For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.

Seven reasons your ADHD medication isn't working. Jonathan Murphy, PMHNP-BC, walks through the clinical patterns that show up when adult ADHD medication fails to deliver the expected response — and what each pattern actually points toward.

This episode covers:

• Why daily consistency matters more than the cultural narrative around "as needed" stimulant use
• Why ADHD is a disorder of inconsistency and how consistent medication produces a different person over time
• The diagnostic question hiding underneath medication non-response: do you actually have ADHD
• The OCPD distinction — patients who don't fluctuate in attention but instead narrow their perception of what's possible
• Why patients with primary ADHD plus secondary anxiety often confuse the two and reach for the wrong primary treatment
• The honeymoon period of stimulant response and why a sudden three-day drop signals underlying depression
• Why immediate-release tablets can't deliver consistent symptom control and what the spike-and-crash actually represents pharmacokinetically
• The undertreatment pattern: 5-10 milligram Adderall starting doses from prescribers uncomfortable with adult ADHD medication
• The 50/50 split between adults who respond best to methylphenidate versus amphetamine
• Why hunting down a specific generic manufacturer creates more problems than it solves
• The Reddit r/ADHD ideology breakdown: how tribal identity formation distorts clinical reasoning around ADHD treatment
• The three components of online ADHD tribal narrative: the idea (our brains are different), the sentiment (it's not fair nobody noticed), the custom (complaint without accountability)
• Why the podcast operates with less filter than the YouTube channel and what that medium difference enables

This is the fifth episode of Actually ADHD. Earlier episodes covered the optimization blueprint, the medication walkthrough, and the Goldilocks Zone framework. The book The Process: An Adult's Guide to ADHD Medication is available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.

For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.

How to know you're on the correct dose of ADHD medication. Jonathan Murphy, PMHNP-BC, breaks down the Goldilocks Zone — the framework for identifying the right dose of stimulant medication for an adult with ADHD. Not too little, not too much, just right.

This episode covers:

• Why there is no universal "right dose" or "best medication" for ADHD
• The Goldilocks Zone: too low means tired, too high means tweaking out, just right means calm and functional
• Duration as part of the optimization equation and what a crash actually signals
• Why side effects and poor toleration are not necessary parts of ADHD treatment
• The pattern of overstimulation on amphetamines pointing toward methylphenidate
• The pattern of zombification on methylphenidate pointing toward non-stimulants or dexmethylphenidate
• Why extended-release technology is what makes optimization possible at all
• Tonic versus phasic dopamine receptor activation and why consistency is the goal
• The myth of toleration and the normal three-to-four-week adjustment from initial response to maintenance dose
• Why the diagnostic criteria of ADHD are validated by medication response, not just by symptom checklist
• The "prescriber as cop" framing: how the Controlled Substance Act has distorted clinical decision-making
• Why a patient who feels shame at the pharmacy can't ask the simple question "how do I know if I'm on the right dose?"
• The role of secondary symptom resolution — forgetfulness and organizational difficulty as downstream effects of consistent medication
• Why one month is the minimum trial period and what shooting at moving targets looks like
• The internet-filtered version of ADHD: how tribal identity formation distorts clinical reasoning
• Why guanfacine monotherapy in adults is sometimes a signal to reconsider the diagnosis, not to celebrate the medication

This is the fourth episode in the sequence covering the optimization process from the book The Process: An Adult's Guide to ADHD Medication, available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.

For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.

A deep dive into the extended-release ADHD stimulant medications. Jonathan Murphy, PMHNP-BC, walks through every major option in the methylphenidate and amphetamine categories, the clinical reasoning behind choosing one over another, and the specific patient presentations that point toward each medication.

This episode covers:

• The two stimulant categories: methylphenidate and amphetamine
• OROS technology in Concerta versus micro-bead technology in newer extended-release formulations
• Why Concerta's absorption can be spotty and when to move to Ritalin LA
• The methylphenidate bead ratios: 50/50, 60/40, 70/30 and what each one does clinically
• Aptensio, Metadate, and Jornay PM as alternatives within the methylphenidate family
• Focalin (dexmethylphenidate) as the second-line methylphenidate when standard formulations don't deliver
• The amphetamine side: Adderall XR, Vyvanse, Dexedrine, and Mydayis
• Why dextroamphetamine-only options (Vyvanse) work better for some patients than mixed amphetamine salts (Adderall)
• The 25-30% of adult patients who do best on a pure dextroamphetamine
• Why "all good, no bad" is the optimization standard, not "good enough"
• The diagnostic value of medication response: if any properly trialed medication works, the diagnosis is confirmed and other options remain available
• Why FDA-recommended dosing limits are appropriate guardrails, not arbitrary restrictions

This episode references the Top 10 ADHD Stimulants video on the Focus Path YouTube channel: https://youtu.be/xJQLSCGY9Vc

This is the third episode in the sequence covering the optimization process from the book The Process: An Adult's Guide to ADHD Medication, available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.

For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.

The Optimization Blueprint — the algorithm Jonathan Murphy, PMHNP-BC, uses to find the right medication and the right dose for adults with ADHD.

This episode is for two audiences simultaneously: clinicians refining their adult ADHD prescribing practice and patients trying to understand whether their current treatment is optimized.

This episode covers:

• The three medication categories: methylphenidate, amphetamine, and non-stimulant
• Why extended-release stimulants are first-line and why the "controlled substance" framing misleads prescribers
• The standard adult starting doses for the major medications
• The response and toleration framework for assessing the first prescription
• When to start with amphetamine versus methylphenidate based on presentation
• Why methylphenidate is often the better starting point despite being less culturally familiar
• What "optimized" actually means: all good, no bad, no side effects, works like a vitamin
• The risk of dysfunctional medication relationships and how they form
• Why providers who haven't developed comfort with adult ADHD prescribing should consider referring out rather than under-treating

This is the second episode in the sequence covering the optimization process from the book The Process: An Adult's Guide to ADHD Medication, available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.

For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.

The first episode of Actually ADHD.

Jonathan Murphy, PMHNP-BC, board-certified psychiatric nurse practitioner with 20,000+ clinical hours specializing in adult ADHD, opens the show with the conversation the internet hasn't been having.

This episode covers:

• Why the book The Process: An Adult's Guide to ADHD Medication exists and why the field needed it
• The clinical history of ADHD from 18th-century behavioral observations to the modern DSM
• Charles Bradley's 1937 discovery at the Emma Pendleton Bradley Home that changed the field
• The pharmacology evolution from immediate-release amphetamine to modern extended-release formulations
• Why adult ADHD treatment is in some ways newer than the patients in it
• The personal story of becoming the ADHD clinician
• Why most prescribers in primary care and general psychiatry struggle with optimization
• What "Actually ADHD" actually means

The book The Process: An Adult's Guide to ADHD Medication is available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

Find the YouTube channel Focus Path | PMHNP-BC for full clinical education content.

For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.